PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair.
Konstantinopoulos, Panagiotis A
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting Mar 2020 - 1-16 p. digital
Publication Type: Journal Article; Review
1548-8756
10.1200/EDBK_288015 doi
Animals
DNA Damage
DNA Repair
Drug Therapy, Combination
Female
Humans
Ovarian Neoplasms--drug therapy
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting Mar 2020 - 1-16 p. digital
Publication Type: Journal Article; Review
1548-8756
10.1200/EDBK_288015 doi
Animals
DNA Damage
DNA Repair
Drug Therapy, Combination
Female
Humans
Ovarian Neoplasms--drug therapy
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use